Could a fatty acid drug stop dangerous blood sugar drops in MCADD?
NCT ID NCT06067802
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 31 times
Summary
This study tests a drug called triheptanoin in 8 adults with MCADD, a genetic condition that can cause dangerously low blood sugar. The drug is already approved for similar disorders. Researchers want to see if it is safe and helps prevent hypoglycemia during fasting. Participants stay overnight at a hospital for monitoring and blood tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
Conditions
Explore the condition pages connected to this study.